Rx (Prescription Medicine)
USD $ 30.00
Lucaparib 200mg Tablet 是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分 Lucaparib 属于一类称为 PARP（多聚腺苷酸基苷酸酶）抑制剂的药物。PARP 酶在细胞的 DNA 修复中起着关键作用。在具有特定基因突变的癌细胞（如 BRCA 基因突变）中，DNA 修复机制已经受损。通过抑制 PARP，Lucaparib 进一步阻止这些癌细胞修复受损的 DNA，从而导致癌细胞死亡。Lucaparib 主要适用于已接受三次或以上化疗的、携带致病或疑似致病的 BRCA 基因突变（通过 FDA 批准的检测方法确定）的转移性卵巢癌、输卵管癌或原发性腹膜癌的成年患者。
推荐剂量通常为 600mg（3 片 200mg 片）每日口服两次。务必严格按照医疗提供者的处方服用 Lucaparib。常见的不良反应可能包括恶心、疲劳、贫血以及肝功能检测的变化。患者应定期监测这些及其他潜在的不良反应。Lucaparib 应储存在室温下，远离潮湿和热源，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Rucaparib. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
